Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?

Leerdam, M.E. van; Latchford, A. (2021)

Other

Familial adenomatous polyposis (FAP) is a rare autosomal dominant inherited disease caused by a pathogenic mutation in the APC gene with a prevalence of about 1 in 8500 to 10,000 births [1]. Patients with “classical FAP” do have a typical phenotype and develop 100 to 1000 adenomas throughout the colon. If left untreated, colorectal cancer will occur at a median age 35 to 45 years. Prophylactic surgery, usually either resection of the colon with an ileo-rectal anastomosis (IRA) or resection of the colon and rectum with an ileo-pouch anal anastomosis (IPAA), is offered to mitigate this risk of cancer. Timing and type of prophylactic surgery depends on the number, size, and histology of the adenomas and should be personalized.

• All authors: Leerdam, M.E. van; Latchford, A.
• Date: 2021-09-01
• Title of host publication: Endoscopy International Open
• Volume: 09
• Issue: 09
• Pages: E1445 - E1446
• DOI: doi:10.1055/a-1521-4912
• Link: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1521...